In a patient with low libido and erectile dysfunction despite supraphysiologic testosterone, which of his medications—trazodone, prazosin, hydroxyzine, or rosuvastatin—is most likely responsible?

Trazodone is the Most Likely Culprit

Among the medications listed, trazodone is the most probable cause of erectile dysfunction and low libido in this patient with supraphysiologic testosterone levels. While prazosin can paradoxically cause priapism rather than ED, and rosuvastatin shows mixed evidence, trazodone has well-documented sexual side effects through multiple mechanisms 1, 2, 3.

Why Trazodone is the Primary Suspect

Trazodone causes sexual dysfunction through several pathways:

• Serotonergic effects: As a serotonin reuptake inhibitor and 5-HT2A receptor antagonist, trazodone increases serotonergic activity, which is known to suppress sexual desire and erectile function 1, 3
• Alpha-1 adrenergic antagonism: This property can contribute to erectile difficulties by affecting vascular tone 1
• Clinical evidence: Studies demonstrate that trazodone causes sexual dysfunction in 12-18% of men for desire/drive problems and 9-15% for arousal/orgasm issues 2

The FDA label explicitly warns about trazodone's effects on sexual function, though interestingly it more commonly discusses priapism as a rare but serious adverse effect 1. However, at typical antidepressant doses (75-300 mg), sexual dysfunction is far more common than priapism.

Why the Other Medications Are Less Likely

Prazosin actually has an unusual profile - it's more associated with priapism (prolonged erections) than erectile dysfunction 4. The FDA label specifically warns about this risk, and research shows prazosin has been studied as a treatment for ED when combined with alprostadil 5. This makes it an unlikely cause of your patient's symptoms.

Hydroxyzine has one case report from 1994 suggesting it might induce prolonged erections through a mechanism similar to trazodone 6, making it an improbable cause of ED.

Rosuvastatin shows conflicting evidence:

• One study found rosuvastatin had no effect on erectile function (IIEF scores unchanged) 7
• Another study showed rosuvastatin decreased free testosterone levels but did not affect sexual function scores 8
• This is particularly relevant since your patient has supraphysiologic testosterone, suggesting the testosterone axis isn't the problem

Clinical Approach

The most direct intervention is to discontinue or reduce the trazodone dose. Consider:

1. Immediate action: Reduce trazodone to the lowest effective dose or discontinue if clinically appropriate for the underlying indication (likely depression, anxiety, or insomnia)

2. Alternative for depression/anxiety: Switch to bupropion, which has neutral or positive effects on sexual function and may actually augment sexual desire 9, 10

3. Alternative for insomnia: Consider non-serotonergic options like low-dose doxepin, ramelteon, or behavioral interventions

4. Reassess in 2-4 weeks: Sexual function typically improves within weeks of discontinuing serotonergic antidepressants 3

Important Caveat

The supraphysiologic testosterone level itself warrants investigation - if the patient is on exogenous testosterone therapy, ensure proper dosing and monitoring. However, since sexual dysfunction persists despite high testosterone, this strongly points to a medication effect rather than hormonal insufficiency 11, 12.

Do not simply add a PDE5 inhibitor without addressing the underlying medication cause - while sildenafil or tadalafil may help the erectile component, they won't address the libido suppression from trazodone 11, 3.